The Thoracic Society of Australia and New Zealand and the Australian Lung Foundation have jointly produced guidelines for the management of chronic obstructive pulmonary disease (COPD).

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.410, 2003-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 669-674

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2053-2062

Bentham Science Publishers

Access to resources Recommend Favorite

From Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines to Current Clinical Practice: An Overview of the Pharmacological Therapy of Stable Chronic Obstructive Pulmonary Disorder

By Raffaele Antonelli Incalzi  

Drugs & Aging, Vol. 23, Iss. 5, 2006-01 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease: consequences beyond the lung

By Shrikrishna Dinesh   Hopkinson Nicholas S  

Clinical Medicine, Vol. 12, Iss. 1, 2012-02 ,pp. : 71-74

Royal College Of Physicians

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease (COPD) may represent a serious threat

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite